The FDA-approved TGFB inhibitor Pirfenidone (5-methyl-1-phenyl-2(1 H)-pyridone, PFD) has been shown to inhibit TGFB expression in malignant glioma cells [37]. The gene discussed is TGFB1; the disease is malignant glioma.